Business Weekly reports that Sortera Bio, an LMB spinout company, has attracted backers for a £7.5m pre-seed round to power AI models for drug discovery. The round was led by Cambridge Innovation Capital (CIC) with participation from AstraZeneca and BioNTech. More…
Sortera Bio has raised £7.5m pre-seed investment from AstraZeneca, BioNTech and CIC
The LMB licences ‘tRNA Display’ technology to Constructive.Bio
Business Weekly reports that Constructive.Bio, an LMB spinout company based on Jason Chin’s research, now holds the exclusive licence to ‘tRNA Display’ technology. The company can start a full commercial rollout of its platform – enabling next-gen synthetic protein engineering applications for pharma, agriculture and advanced materials. More…
Tanmay Bharat awarded EMBO Gold Medal
Tanmay Bharat, Group Leader in the LMB’s Structural Studies Division, received EMBO’s Gold Medal in recognition of his work on prokaryotic surface molecules.
Matt Higgins and Jernej Ule elected Fellows of the Academy of Medical Sciences
Higgins: LMB 1997-2007, PhD student; Postdoctoral Scientist, Neurobiology; Structural StudiesUle: LMB 2006-2013, Group Leader, Structural Studies Congratulations to alumni Matt Higgins and Jernej Ule who have both been elected Fellows of the Academy of Medical Sciences. Matt now leads a group at the University of Oxford’s Department of Biochemistry, where he conducts structural studies to […]
Leo James, Greg Jefferis and Marta Zlatic elected to Royal Society
Leo James, PNAC Division, Greg Jefferis and Marta Zlatic, both Neurobiology Division, are amongst the 85 new Fellows elected to the Royal Society.
Oscar Despard captains Christ’s College to first University Challenge victory
Oscar Despard, PhD student in the LMB’s Cell Biology Division, discusses competing in a nail-bitingly close final match in University Challenge.